Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: A retrospective review from a single center

Cardiovascular Revascularization Medicine

Volumn 13, Issue 4, 2012, Pages 224-227

  Shammas, Nicolas W ^a   Shammas, Gail A ^a   Helou, Timothy J ^a   Voelliger, Cara M ^a   Mrad, Luay ^a   Jerin, Michael ^a  

^a MIDWEST CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

Atherectomy; Femoropopliteal segment; In stent restenosis; Long term outcome; SilverHawk

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HIRULOG;

AGED; AMPUTATION; ANKLE BRACHIAL INDEX; ARTICLE; ARTIFICIAL EMBOLISM; ATHERECTOMY; BLOOD VESSEL DIAMETER; CHRONIC KIDNEY FAILURE; CIGARETTE SMOKING; CLINICAL ARTICLE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FEMOROPOPLITEAL ARTERY; FOLLOW UP; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; PRIORITY JOURNAL; REVASCULARIZATION; SAFETY; SILVERHAWK ATHERECTOMY; STENT THROMBOSIS; TARGET LESION REVASCULARIZATION; TARGET VESSEL REVASCULARIZATION;

AGED; ANGIOPLASTY, BALLOON; ANTICOAGULANTS; ATHERECTOMY; COMBINED MODALITY THERAPY; CONSTRICTION, PATHOLOGIC; EMBOLIC PROTECTION DEVICES; EQUIPMENT DESIGN; FEMALE; FEMORAL ARTERY; HUMANS; IOWA; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; POPLITEAL ARTERY; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864143625     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2012.03.004     Document Type: Article

References (9)

1. Yeo K.K., Malik U., Laird J.R. Outcomes following treatment of femoropopliteal in-stent restenosis: a single center experience. Catheter Cardiovasc Interv 2011, 78(4):604-608.
2. Trentmann J., Charalambous N., Djawanscher M., et al. Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery. Cardiovasc Surg (Torino) 2010, 51(4):551-560.
3. Zeller T., Rastan A., Sixt S., et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol 2006, 48(8):1573-1578.
4. Laird J.R., Katzen B.T., Scheinert D., et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010, 3(3):267-276.
5. Schillinger M., Sabeti S., Loewe C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006, 354(18):1879-1888.
6. Shammas N.W., Coiner D., Shammas G.A., et al. Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. J Vasc Interv Radiol 2011, 22:1223-1228.
7. Dick P., Sabeti S., Mlekush W., et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology 2008, 248:297-302.
8. Shammas N.W., Dippel E.J., Coiner D., et al. Preventing lower extremity distal embolization using embolic filter protection: results of the PROTECT registry. JEndovasc Ther 2008, 15:270-276.
9. Suri R., Wholey M.H., Postoak D., et al. Distal embolic protection during femoropopliteal atherectomy. Catheter Cardiovasc Interv 2006, 67:417-422.